Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils

被引:12
作者
Braun, RK [1 ]
Foerster, M [1 ]
Workalemahu, G [1 ]
Haefner, D [1 ]
Kroegel, C [1 ]
Walker, C [1 ]
机构
[1] Univ Jena, Med Clin 4, Dept Pneumol Allergy & Immunol, D-07740 Jena, Germany
关键词
aminopeptidase N; endothelial cells; eosinophils; interleukin-3; interleukin-5; transendothelial migration;
D O I
10.1080/01902140303766
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Aminopeptidase N (CD13) is a cell surface metalloprotease involved in growth regulation, tumor invasion, and down-regulation of regulatory peptides. CD13 expression on eosinophils in bronchoalveolar lavage (BAL) of asthmatics 10 minutes and 18 hours after segmental allergen provocation was significantly increased (+225% to +294%) compared to blood eosinophils. In vitro CD13 expression could be induced on blood eosinophils by transendothelial migration of the cells across interlenkin (IL) 1beta-activated human umbilical cord vein endothelial cells (HUVECs) as well as by the exposure to the cytokines IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF). The cytokines GM-CSF and IL-5 were significantly less effective in inducing CD13 compared to IL-3. The IL-3-induced expression of CD13 was decreased in the presence of the protein-synthesis inhibitor cycloheximide (-8.8%). Moreover, blocking of CD13 by the protease inhibitors actinonin and bestatin significantly enhanced migration (+40.0% to +80.0%) of eosinophils across HUVEC monolayers. In summary, the data suggest that CD13 is regulated both by the process of transmigration and by the cytokine IL-3. Further, CD13 itself seems to be involved in the process of eosinophil transmigration.
引用
收藏
页码:59 / 77
页数:19
相关论文
共 41 条
[1]  
Amoscato AA, 1998, J IMMUNOL, V161, P4023
[2]   INCREASES IN ACTIVATED T-LYMPHOCYTES, EOSINOPHILS, AND CYTOKINE MESSENGER-RNA EXPRESSION FOR INTERLEUKIN-5 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN BRONCHIAL BIOPSIES AFTER ALLERGEN INHALATION CHALLENGE IN ATOPIC ASTHMATICS [J].
BENTLEY, AM ;
MENG, Q ;
ROBINSON, DS ;
HAMID, Q ;
KAY, AB ;
DURHAM, SR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (01) :35-42
[3]  
Burdach S, 1998, Curr Opin Hematol, V5, P177, DOI 10.1097/00062752-199805000-00005
[4]   Inflammation in asthma: The cornerstone of the disease and target of therapy [J].
Busse, WW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :S17-S22
[5]  
CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075
[6]  
COHEN ML, 1983, J PHARMACOL EXP THER, V224, P379
[7]   Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation [J].
Danzig, M ;
Cuss, F .
ALLERGY, 1997, 52 (08) :787-794
[8]  
DELANCE RJ, 1971, ENZYMES, P81
[9]   EOSINOPHILIA IN TRANSGENIC MICE EXPRESSING INTERLEUKIN-5 [J].
DENT, LA ;
STRATH, M ;
MELLOR, AL ;
SANDERSON, CJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1425-1431
[10]  
DVORAK AM, 1990, BLOOD CELL BIOCH, V2, P237